Compare Stocks: PFSA, AMIX, ZYXI, and BJDX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMIX Autonomix Medical	$3.98 -3.6%	$5.63	$2.44 ▼ $32.55	$3.86M	-1	1.59 million shs	55,170 shs
BJDX Bluejay Diagnostics	$0.97 -3.1%	$0.99	$0.80 ▼ $16.68	$4.33M	0.91	2.50 million shs	733,190 shs
PFSA Profusa	$2.05 -5.5%	$4.79	$1.58 ▼ $3,000.00	$1.24M	0.49	455,458 shs	1.80 million shs
ZYXI Zynex	$0.13	$0.12	$0.12 ▼ $2.82	$3.80M	0.99	2.32 million shs	N/A

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMIX Autonomix Medical	+1.98%	-1.90%	-21.63%	-42.72%	-82.28%
BJDX Bluejay Diagnostics	+9.65%	+17.98%	+9.78%	-66.56%	-83.55%
PFSA Profusa	+11.86%	+18.58%	-60.26%	-83.31%	+216,999,900.00%
ZYXI Zynex	0.00%	0.00%	0.00%	0.00%	-92.09%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMIX Autonomix Medical	$3.98 -3.6%	$5.63	$2.44 ▼ $32.55	$3.86M	-1	1.59 million shs	55,170 shs
BJDX Bluejay Diagnostics	$0.97 -3.1%	$0.99	$0.80 ▼ $16.68	$4.33M	0.91	2.50 million shs	733,190 shs
PFSA Profusa	$2.05 -5.5%	$4.79	$1.58 ▼ $3,000.00	$1.24M	0.49	455,458 shs	1.80 million shs
ZYXI Zynex	$0.13	$0.12	$0.12 ▼ $2.82	$3.80M	0.99	2.32 million shs	N/A

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMIX Autonomix Medical	+1.98%	-1.90%	-21.63%	-42.72%	-82.28%
BJDX Bluejay Diagnostics	+9.65%	+17.98%	+9.78%	-66.56%	-83.55%
PFSA Profusa	+11.86%	+18.58%	-60.26%	-83.31%	+216,999,900.00%
ZYXI Zynex	0.00%	0.00%	0.00%	0.00%	-92.09%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMIX Autonomix Medical	2.00	Hold	$42.00	967.34% Upside
BJDX Bluejay Diagnostics	1.00	Sell	N/A	N/A
PFSA Profusa	1.00	Sell	N/A	N/A
ZYXI Zynex	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest PFSA, AMIX, ZYXI, and BJDX Analyst Ratings

Date	Company	Brokerage	Action	Rating
9/21/2026	BJDX Bluejay Diagnostics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
8/27/2026	PFSA Profusa	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)
8/14/2026	PFSA Profusa	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (E+) ➝ Sell (E)
7/28/2026	AMIX Autonomix Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)
7/10/2026	AMIX Autonomix Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (E+) ➝ Sell (E)
6/24/2026	BJDX Bluejay Diagnostics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/24/2026	PFSA Profusa	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/23/2026	AMIX Autonomix Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)

(Data available from 9/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMIX Autonomix Medical	N/A	N/A	N/A	N/A	$10.85 per share	N/A
BJDX Bluejay Diagnostics	N/A	N/A	N/A	N/A	$8.43 per share	N/A
PFSA Profusa	$100K	13.76	N/A	N/A	($2,168.90) per share	0.00
ZYXI Zynex	$108.20M	0.04	$0.25 per share	0.51	$1.12 per share	0.11

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMIX Autonomix Medical	-$16.72M	-$41.57	N/A	N/A	N/A	N/A	-267.73%	-216.75%	11/11/2026 (Estimated)
BJDX Bluejay Diagnostics	-$6.85M	-$7.11	N/A	N/A	N/A	N/A	-125.00%	-99.79%	11/13/2026 (Estimated)
PFSA Profusa	-$35.82M	-$5,619.96	N/A	N/A	N/A	N/A	N/A	-1,731.09%	N/A
ZYXI Zynex	$2.99M	-$2.43	N/A	0.27	N/A	-68.35%	-804.30%	-36.67%	N/A

Latest PFSA, AMIX, ZYXI, and BJDX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/19/2026	Q2 2026	PFSA Profusa	N/A	-$151.80	N/A	-$151.80	N/A	N/A
8/12/2026	Q1 2027	AMIX Autonomix Medical	-$6.40	-$5.02	+$1.38	-$5.02	N/A	N/A
8/12/2026	Q2 2026	BJDX Bluejay Diagnostics	-$3,520.00	-$1.12	+$3,518.88	-$1.12	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMIX Autonomix Medical	N/A	N/A	N/A	N/A	N/A
BJDX Bluejay Diagnostics	N/A	N/A	N/A	N/A	N/A
PFSA Profusa	N/A	N/A	N/A	N/A	N/A
ZYXI Zynex	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMIX Autonomix Medical	N/A	4.85	4.85
BJDX Bluejay Diagnostics	N/A	4.64	4.64
PFSA Profusa	N/A	0.03	0.03
ZYXI Zynex	0.56	0.47	0.32

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMIX Autonomix Medical	10.78%
BJDX Bluejay Diagnostics	18.47%
PFSA Profusa	9.81%
ZYXI Zynex	29.68%

Insider Ownership

Company	Insider Ownership
AMIX Autonomix Medical	5.50%
BJDX Bluejay Diagnostics	6.10%
PFSA Profusa	15.00%
ZYXI Zynex	49.28%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMIX Autonomix Medical	11	970,000	918,000	N/A
BJDX Bluejay Diagnostics	6	4.47 million	4.20 million	Not Optionable
PFSA Profusa	2	610,000	515,000	N/A
ZYXI Zynex	770	30.39 million	15.41 million	No Data

PFSA, AMIX, ZYXI, and BJDX Headlines

Recent News About These Companies

Contrasting Anteris Technologies Global (NASDAQ:AVR) and Zynex (NASDAQ:ZYXI)

September 21 at 7:45 AM | americanbankingnews.com

Kuehn Law Encourages Investors of Zynex, Inc. to Contact Law Firm

July 21, 2026 | prnewswire.com

Kuehn Law Encourages Investors of Zynex, Inc. to Contact Law Firm

July 13, 2026 | globenewswire.com

ZYXIQ CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026

April 21, 2026 | newsfilecorp.comN

ZYXIQ INVESTOR ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Zynex, Inc.

April 16, 2026 | globenewswire.com

ZYNEX LEAD PLAINTIFF DEADLINE APPROACHING: Bragar Eagel & Squire, P.C. Reminds Zynex, Inc Investors to Contact the Firm Before the April 21st Lead Plaintiff Deadline

April 13, 2026 | globenewswire.com

Levi & Korsinsky Notifies Zynex, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline â€“ ZYXIQ

April 13, 2026 | globenewswire.com

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Zynex, Inc. (ZYXIQ)

April 10, 2026 | globenewswire.com

ZYXIQ Shareholder Alert: April 21, 2026 Lead Plaintiff Deadline in Zynex, Inc. Securities Class Action Lawsuit â€” The Gross Law Firm

April 10, 2026 | globenewswire.com

ZYXIQ EQUITY ALERT: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026

April 9, 2026 | newsfilecorp.comN

ZYXIQ INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Zynex Investors of Securities Class Action Deadline on April 21, 2026

April 3, 2026 | prnewswire.com

ZYXIQ UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026

April 1, 2026 | globenewswire.com

Zynex, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 21, 2026 to Discuss Your Rights - ZYXIQ

April 1, 2026 | prnewswire.com

ZYXI SHAREHOLDER ALERT: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements

March 30, 2026 | prnewswire.com

ZYXIQ Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Zynex, Inc. Securities Lawsuit â€” The Gross Law Firm

March 27, 2026 | globenewswire.com

ZYXI SHAREHOLDER UPDATE: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements

March 24, 2026 | prnewswire.com

ZYXIQ CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026

March 23, 2026 | newsfilecorp.comN

ZYXI ALERT: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements

March 20, 2026 | prnewswire.com

ZYXI SHAREHOLDER NOTICE: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements

March 19, 2026 | globenewswire.com

Shareholders that lost money on Zynex, Inc. (ZYXIQ) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

March 18, 2026 | prnewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

PFSA, AMIX, ZYXI, and BJDX Company Descriptions

Autonomix Medical NASDAQ:AMIX

$3.98 -0.15 (-3.63%)

Closing price 04:00 PM Eastern

Extended Trading

$4.03 +0.05 (+1.13%)

As of 05:24 PM Eastern

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

Bluejay Diagnostics NASDAQ:BJDX

$0.97 -0.03 (-3.12%)

Closing price 04:00 PM Eastern

Extended Trading

$0.95 -0.02 (-1.63%)

As of 05:33 PM Eastern

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Profusa NASDAQ:PFSA

$2.05 -0.12 (-5.53%)

Closing price 04:00 PM Eastern

Extended Trading

$2.07 +0.02 (+1.12%)

As of 05:35 PM Eastern

NorthView Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare sector. The company was incorporated in 2021 and is based in New York, New York. NorthView Acquisition Corporation is a subsidiary of NorthView Sponsor I, LLC.

Zynex NASDAQ:ZYXI

$0.12 0.00 (0.00%)

As of 09/22/2026

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PFSA, AMIX, ZYXI, and BJDX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PFSA, AMIX, ZYXI, and BJDX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PFSA, AMIX, ZYXI, and BJDX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PFSA, AMIX, ZYXI, and BJDX Company Descriptions

Autonomix Medical NASDAQ:AMIX

Bluejay Diagnostics NASDAQ:BJDX

Profusa NASDAQ:PFSA

Zynex NASDAQ:ZYXI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PFSA, AMIX, ZYXI, and BJDX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PFSA, AMIX, ZYXI, and BJDX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PFSA, AMIX, ZYXI, and BJDX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PFSA, AMIX, ZYXI, and BJDX Company Descriptions

Autonomix Medical NASDAQ:AMIX

Bluejay Diagnostics NASDAQ:BJDX

Profusa NASDAQ:PFSA

Zynex NASDAQ:ZYXI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools